Loading...
Pharmacokinetics of quinacrine in the treatment of prion disease
BACKGROUND: Prion diseases are caused by the accumulation of an aberrantly folded isoform of the prion protein, designated PrP(Sc). In a cell-based assay, quinacrine inhibits the conversion of normal host prion protein (PrP(C)) to PrP(Sc )at a half-maximal concentration of 300 nM. While these data s...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2004
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC535929/ https://ncbi.nlm.nih.gov/pubmed/15569390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-4-53 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|